advertisement
Vavvas DG 27
Showing records 1 to 25 | Display all abstracts from Vavvas DG104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Moos WH
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Saini C
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Faller DV
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Chen TC
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Glavas IP
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Young LH; Vavvas DG
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Harpp DN
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Vangel M
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Kamperi N
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Papaliodis GN
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Kanara I
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Mukai S
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Kodukula K
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Turalba AV
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Mavrakis AN; Pernokas J
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Rhee DJ; Wu DM
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Pernokas M
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Eliott D
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Pinkert CA; Powers WR
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Miller JB; Song BJ
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Sampani K
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Shen LQ
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Steliou K; Tamvakopoulos C
Biochemical Pharmacology 2022; 203: 115168
104671 Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
Pasquale LR
American Journal of Ophthalmology 2022; 243: 42-54
104635 Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury
Vavvas DG
Biochemical Pharmacology 2022; 203: 115168